Johnson & Johnson (DJNJ2)

235.50 -19.50 (-7.65%)
Closed ARS Disclaimer

DJNJ2 Financial Summary

For the nine months ended 03 October 2021, Johnson &Johnson revenues increased 15% to $68.97B. Net incomebefore extraordinary items increased 27% to $16.14B.Revenues reflect Pharmaceutical segment increase of 13% to$37.79B, Medical Devices segment increase of 23% to $20.2B,United States segment increase of 12% to $34.99B, Europesegment increase of 22% to $16.67B. Net income benefitedfrom Gains on securities increase of 50% to $300M (income).
TTM
Trailing Twelve Months
MRQ
Most Recent Quarter
DJNJ2
Gross margin TTM 67.59%
Operating margin TTM 21.42%
Net Profit margin TTM 19.55%
Return on Investment TTM -
Total Revenue
Net Income
Title
Oct 03, 2021
Jul 04, 2021
Apr 04, 2021
Jan 03, 2021
Total Revenue 23,338 23,312 22,321 22,475
Gross Profit 16,088 15,725 15,258 14,692
Operating Income 3,849 6,662 7,429 1,647
Net Income 3,667 6,278 6,197 1,738
Clear All
0Selected
Please try another search
DJNJ2
Quick Ratio MRQ -
Current Ratio MRQ -
LT Debt to Equity MRQ -
Total Debt to Equity MRQ -
Total Assets
Total Liabilities
Title
Oct 03, 2021
Jul 04, 2021
Apr 04, 2021
Jan 03, 2021
Total Assets 179,228 176,440 172,557 174,894
Total Liabilities 108,956 106,860 106,723 111,616
Total Equity 70,272 69,580 65,834 63,278
Clear All
0Selected
Please try another search
DJNJ2
Cash Flow/Share TTM 7.44
Revenue/Share TTM 34.22
Operating Cash Flow 39.67%
Cash
Net Change in Cash
Title
Oct 03, 2021
Jul 04, 2021
Apr 04, 2021
Jan 03, 2021
Cash From Operating Activities 17,678 9,388 4,074 23,536
Cash From Investing Activities -3,323 -604 -185 -20,825
Cash From Financing Activities -10,611 -8,404 -5,125 -6,120
Net Change in Cash 3,619 347 -1,314 -3,320
Clear All
0Selected
Please try another search

* In Millions of (except for per share items)

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.